Susan Hasty, Publisher
Table of Contents . . . December 12th, 2001
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Vaccine Weekly | Other Publications
Bioterrorism - U.S. Opts To Keep Smallpox Stock
Immunology - Oral DNA Vaccines Depend On Macrophages For Hepatitis B Immune Response
AIDS and HIV Vaccine - Monoclonal Antibodies Display Mysterious Synergy
Advocacy - Pain, Price, Insurance Delays Associated With Vaccines Worry Doctors
Immunosuppression - Ultraviolet B Exposure Has No Bearing On Hepatitis B Vaccine Effectiveness
Tumor Vaccine - CpG Oligonucleotides Generate Antitumor Response In Rodents
AIDS Therapies - Vical To Receive $3 Million Milestone Payment
Adjuvants - BioSante Licenses Technology To Corixa
Adjuvants - Synergy Vaccines Reaches Milestone with SynerVax-HB Hepatitis Vaccine
Bioterrorism - Poll Finds That Americans Fear Bioterror, Want Vaccinations
Epidemiology - Immunization Tracking Software Aids U.S. Army Soldier Readiness
Facilities - Avax Receives FDA Warning Letter Regarding Inspection
HIV Vaccine - HIV Specific T Cells May Not Be Crucial For Early Protection
Influenza - Healthy Americans Now Encouraged To Get Immunized
Kidney Cancer - Genetically Engineered T Cell Tackles Tumors
Malaria - DNA Vaccine Is Safe And Immunogenic
Nicotine Addiction - Preclinical Safety Testing Of Nicotine Vaccine Completed
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.